Blog
RSS FeedPosted by Michael Wonder on 16 Jul 2025
Call for RSV vaccine subsidies for elderly as severe hospitalisations on rise
16 July 2025 - RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of ...
Posted by Michael Wonder on 21 Mar 2025
Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting
21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 19 Jan 2025
Protection against RSV for mums and bubs with free vaccine available from 3 February
19 January 2025 - From 3 February 2025, Australian mums and their newborn babies will have free access to the best ...
Posted by Michael Wonder on 10 Dec 2024
Moderna’s mRNA vaccines to be exempted from advisory committee scrutiny under $2 billion Morrison era deal
10 December 2024 - Critics say exemption ‘deeply concerning’ and risks creating separate assessment systems. ...
Posted by Michael Wonder on 11 Nov 2024
World leading approach to protect babies from RSV
10 November 2024 - Australian mums and their newborn babies will have free access to the best and most comprehensive ...
Posted by Michael Wonder on 04 Nov 2024
NS parents dismayed by lack of access to new RSV vaccines for infants
3 November 2024 - Officials say there is no universally available, publicly funded RSV vaccine program for newborns in Nova Scotia. ...
Posted by Michael Wonder on 18 Oct 2024
PHARMAC seeking bids from suppliers for COVID-19 vaccines
17 October 2024 - PHARMAC is seeking bids from pharmaceutical suppliers of COVID-19 vaccines. ...
Posted by Michael Wonder on 23 Sep 2024
More Australians now eligible for free shingles vaccination
22 September 2024 - The Albanese Government is expanding one of the most comprehensive and widely available shingles vaccination programs ...
Posted by Michael Wonder on 21 Sep 2024
New COVID-19 vaccine by Moderna approved by Health Canada
17 September 2024 - Health Canada has approved an updated version of Moderna’s COVID-19 vaccine, a decision that means some ...
Posted by Michael Wonder on 20 Sep 2024
Abrysvo: Pfizer Canada's newly publicly funded vaccine a step towards national RSV prevention in older adults
19 September 2024 - Today, Pfizer Canada announced that Abrysvo has been selected as the publicly funded vaccine for the ...
Posted by Michael Wonder on 19 Sep 2024
Program to protect SA newborns from RSV
17 September 2024 - South Australia will protect newborn babies from the impacts of respiratory syncytial virus for the winter ...
Posted by Michael Wonder on 25 Aug 2024
Vulnerable Aussies may remain unprotected against severe RSV
24 August 2024 - There are mounting concerns that Australians at greatest risk of severe respiratory syncytial virus will miss ...
Posted by Michael Wonder on 30 Jun 2024
New Zealand Pharmaceutical Schedule - 1 July 2024
1 July 2024 - July 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Jun 2024
2024-25 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
28 June 2024 - 2024-25 PBS) and NIP cost recovery fees commence on 1 July 2024. ...
Posted by Michael Wonder on 21 Jun 2024
Outcomes from the May 2024 PBAC intracycle meeting
21 June 2024 - Recommendations made by the PBAC in May 2024 relating to the listing of medicines on the PBS ...